Caseware UK (AP4) 2025.0.111 2025.0.111 2026-03-312026-03-312026-05-13false2025-04-01trueNo description of principal activity00falsetrue 07584134 2025-04-01 2026-03-31 07584134 2024-04-01 2025-03-31 07584134 2026-03-31 07584134 2025-03-31 07584134 c:Director1 2025-04-01 2026-03-31 07584134 d:ShareCapital 2026-03-31 07584134 d:ShareCapital 2025-03-31 07584134 c:EntityHasNeverTraded 2025-04-01 2026-03-31 07584134 c:FRS102 2025-04-01 2026-03-31 07584134 c:AuditExempt-NoAccountantsReport 2025-04-01 2026-03-31 07584134 c:FullAccounts 2025-04-01 2026-03-31 07584134 c:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 07584134 e:PoundSterling 2025-04-01 2026-03-31 iso4217:GBP xbrli:pure

Registered number: 07584134










IBD LICENSING LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 MARCH 2026

 
IBD LICENSING LIMITED
REGISTERED NUMBER: 07584134

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2026

2026
2025
Note
£
£

  

Current assets
  

Cash at bank and in hand
 3 
2
2

  
2
2

Total assets less current liabilities
  
 
 
2
 
 
2

  

Net assets
  
2
2


Capital and reserves
  

Called up share capital 
  
2
2

  
2
2


For the year ended 31 March 2026 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the income statement in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 13 May 2026.




M van Beek
Director

The notes on page 2 form part of these financial statements.

Page 1

 
IBD LICENSING LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1.


General information

IBD Licensing Limited is a private company, limited by shares and incorporated in England.

Its registered number is: 07584134

The address of its Registered office is:
Invision House
Wilbury Way
Hitchin
Hertfordshire
SG4 0TY

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.


3.


Cash and cash equivalents

2026
2025
£
£

Cash at bank and in hand
2
2

2
2


Page 2